We Think CRISPR Therapeutics (NASDAQ:CRSP) Can Easily Afford To Drive Business Growth

Yahoo FinanceOct 19 22:36

Truist Financial Maintains CRISPR Therapeutics(CRSP.US) With Buy Rating

Futu NewsOct 18 19:31 · Ratings

Truist Financial Sticks to Its Buy Rating for Crispr Therapeutics AG (CRSP)

TipRanksOct 18 19:05 · Ratings

Is CRISPR Therapeutics AG (CRSP) the Most Promising Biotech Stock According to Hedge Funds?

Yahoo FinanceOct 17 03:47

7 Children Given Bluebird's Skysona Developed Blood Cancer: Study

Seeking AlphaOct 11 04:56

Cathie Wood's ARK Sheds Robinhood Stock, Adds to Amazon and Coinbase

InvestingOct 9 08:10